Model Number AFP |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/13/2022 |
Event Type
malfunction
|
Event Description
|
The initial reporter questioned high results not corresponding to the clinical picture for 1 patient tested for elecsys afp assay (afp) on a cobas 8000 e 602 module.The results were believed to be too high as the patient has no signs or symptoms of any disease; other results (thyroid, other tumor markers) and examinations (routine blood and b-ultrasonic) showed no abnormalities.The patient is healthy and has no other known disease.The patient does not take any medication and does not receive any treatment.It is not known if the patient takes any dietary supplements.The initial result from the e602 module was 30956 ng/ml.The sample was repeated with a result of 36091 ng/ml.Another result from the e602 module was allegedly 33639 ng/ml.The results were reported outside of the laboratory.The afp results were reported to be similar using other methods.The e602 module serial number was (b)(4).
|
|
Manufacturer Narrative
|
Medwatch field address 2 continued: (b)(6).The customer suspected an interference and performed a polyethylene glycol precipitation (peg) experiment and a spike experiment using calf serum: the peg experiment result was 16433 ng/ml.The calf serum experiment result was 6928 ng/ml.Calibration was last performed on (b)(6) 2022 and was acceptable.In this case, calibration was last performed 4 months ago.Product labeling states: renewed calibration is recommended as follows: after 1 month (28 days) when using the same reagent lot.After 7 days (when using the same reagent kit on the analyzer).As required: e.G.Quality control findings outside the defined limits.The qc material used by the customer expired in apr-2021.The measuring cells were last replaced in (b)(6) 2021.Sample material from the patient was requested for investigation.The investigation is ongoing.
|
|
Manufacturer Narrative
|
Medwatch field b6 was updated.The patient does not have liver disease (eg: liver cancer, alcoholic liver disease), hepatitis, cirrhosis or any type of ovarian cancer.It was clarified that the patient does not take any dietary supplements or traditional medicine.
|
|
Manufacturer Narrative
|
The patient sample was received for investigation.The customer's high results were reproduced during the investigation (> 30000 ng/ml).A dilution experiment was performed with good linearity results; there were no signs of an interference and no implausible results.The sample was tested by the elecsys method and the elisa method and similar results were obtained: a mean result 40096 ng/ml (elecsys) and a mean result of 31620 ng/ml (elisa).The investigation noted that the experiments performed by the customer also do not indicate an interference.It is possible for healthy adults to have elevated afp results that may be caused by the hereditary persistence of -fetoprotein (hpafp).Based on the information available, there is no evidence of an interference in the patient sample causing the high afp results.The investigation determined the high afp results, in this case, are considered to be the true results.The investigation did not identify a product problem.The specific cause of the event could not be determined.
|
|
Search Alerts/Recalls
|